Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology

To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine le...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of hospital infection 2006-05, Vol.63 (1), p.93-100
Hauptverfasser: Sax, H., Posfay-Barbe, K., Harbarth, S., Francois, P., Touveneau, S., Pessoa-Silva, C.L., Schrenzel, J., Dharan, S., Gervaix, A., Pittet, D.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 100
container_issue 1
container_start_page 93
container_title The Journal of hospital infection
container_volume 63
creator Sax, H.
Posfay-Barbe, K.
Harbarth, S.
Francois, P.
Touveneau, S.
Pessoa-Silva, C.L.
Schrenzel, J.
Dharan, S.
Gervaix, A.
Pittet, D.
description To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.
doi_str_mv 10.1016/j.jhin.2005.11.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67889107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0195670106000053</els_id><sourcerecordid>67889107</sourcerecordid><originalsourceid>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</originalsourceid><addsrcrecordid>eNqFkUurFDEQhYMo3vHqH3AhvdGVPabSNy9wI4MvuOBCXYd0utrJkE7GJC3MvzfDDNydroo6fFUcziHkJdAtUBDvDtvD3scto5RvAbZNekQ2wAfWMz3ox2RDQfNeSAo35FkpB0pp0_lTcgOC3zHJxYbsdynWnEKX5s52LqylYj4vLi3LGn099baU5LytOL3tFqx773wIPvYZiy_Vxtp9r_a4P4XkknNr6eyasQ0fu4gp2ppC-nV6Tp7MNhR8cZ235Oenjz92X_r7b5-_7j7c927QovZqgomPrllVfByUUgwnRtmsGRd6hJFr5uYJ3CD1zGepQDAcphFQW2WFFsMteXP5e8zp94qlmsUXhyHYZmYtRkilNFD5XxAkCKGkaiC7gC6nUjLO5pj9YvPJADXnIszBnIsw5yIMgGlSO3p1_b6OC04PJ9fkG_D6CtjibJizjc6XB07KOyaANe79hcMW2h-P2RTnMTqcfEZXzZT8v3z8BVsXqEo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17166878</pqid></control><display><type>article</type><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</creator><creatorcontrib>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</creatorcontrib><description>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</description><identifier>ISSN: 0195-6701</identifier><identifier>EISSN: 1532-2939</identifier><identifier>DOI: 10.1016/j.jhin.2005.11.016</identifier><identifier>PMID: 16542756</identifier><language>eng</language><publisher>Kent: Elsevier Ltd</publisher><subject>Adult ; Anti-Bacterial Agents - therapeutic use ; Antibacterial agents ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Bacterial diseases ; Biological and medical sciences ; Community-Acquired Infections - microbiology ; Community-Acquired Infections - prevention &amp; control ; Community-Acquired Infections - transmission ; Community-associated infections/microbiology/transmission ; Cross-infection/microbiology/transmission ; Disease Outbreaks ; Disease transmission, vertical ; Human bacterial diseases ; Humans ; Infant, Newborn ; Infection Control - methods ; Infectious diseases ; Intensive Care Units, Neonatal ; Medical sciences ; Methicillin Resistance ; Pharmacology. Drug treatments ; Staphylococcal Infections - drug therapy ; Staphylococcal Infections - epidemiology ; Staphylococcal Infections - transmission ; Staphylococcal infections, streptococcal infections, pneumococcal infections ; Staphylococcal infections/microbiology/transmission ; Staphylococcus aureus ; Staphylococcus aureus - drug effects ; Staphylococcus aureus - isolation &amp; purification ; Staphylococcus aureus - pathogenicity ; Switzerland - epidemiology</subject><ispartof>The Journal of hospital infection, 2006-05, Vol.63 (1), p.93-100</ispartof><rights>2006 The Hospital Infection Society</rights><rights>2006 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</citedby><cites>FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.jhin.2005.11.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17742612$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16542756$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sax, H.</creatorcontrib><creatorcontrib>Posfay-Barbe, K.</creatorcontrib><creatorcontrib>Harbarth, S.</creatorcontrib><creatorcontrib>Francois, P.</creatorcontrib><creatorcontrib>Touveneau, S.</creatorcontrib><creatorcontrib>Pessoa-Silva, C.L.</creatorcontrib><creatorcontrib>Schrenzel, J.</creatorcontrib><creatorcontrib>Dharan, S.</creatorcontrib><creatorcontrib>Gervaix, A.</creatorcontrib><creatorcontrib>Pittet, D.</creatorcontrib><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><title>The Journal of hospital infection</title><addtitle>J Hosp Infect</addtitle><description>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</description><subject>Adult</subject><subject>Anti-Bacterial Agents - therapeutic use</subject><subject>Antibacterial agents</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Bacterial diseases</subject><subject>Biological and medical sciences</subject><subject>Community-Acquired Infections - microbiology</subject><subject>Community-Acquired Infections - prevention &amp; control</subject><subject>Community-Acquired Infections - transmission</subject><subject>Community-associated infections/microbiology/transmission</subject><subject>Cross-infection/microbiology/transmission</subject><subject>Disease Outbreaks</subject><subject>Disease transmission, vertical</subject><subject>Human bacterial diseases</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>Infection Control - methods</subject><subject>Infectious diseases</subject><subject>Intensive Care Units, Neonatal</subject><subject>Medical sciences</subject><subject>Methicillin Resistance</subject><subject>Pharmacology. Drug treatments</subject><subject>Staphylococcal Infections - drug therapy</subject><subject>Staphylococcal Infections - epidemiology</subject><subject>Staphylococcal Infections - transmission</subject><subject>Staphylococcal infections, streptococcal infections, pneumococcal infections</subject><subject>Staphylococcal infections/microbiology/transmission</subject><subject>Staphylococcus aureus</subject><subject>Staphylococcus aureus - drug effects</subject><subject>Staphylococcus aureus - isolation &amp; purification</subject><subject>Staphylococcus aureus - pathogenicity</subject><subject>Switzerland - epidemiology</subject><issn>0195-6701</issn><issn>1532-2939</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUurFDEQhYMo3vHqH3AhvdGVPabSNy9wI4MvuOBCXYd0utrJkE7GJC3MvzfDDNydroo6fFUcziHkJdAtUBDvDtvD3scto5RvAbZNekQ2wAfWMz3ox2RDQfNeSAo35FkpB0pp0_lTcgOC3zHJxYbsdynWnEKX5s52LqylYj4vLi3LGn099baU5LytOL3tFqx773wIPvYZiy_Vxtp9r_a4P4XkknNr6eyasQ0fu4gp2ppC-nV6Tp7MNhR8cZ235Oenjz92X_r7b5-_7j7c927QovZqgomPrllVfByUUgwnRtmsGRd6hJFr5uYJ3CD1zGepQDAcphFQW2WFFsMteXP5e8zp94qlmsUXhyHYZmYtRkilNFD5XxAkCKGkaiC7gC6nUjLO5pj9YvPJADXnIszBnIsw5yIMgGlSO3p1_b6OC04PJ9fkG_D6CtjibJizjc6XB07KOyaANe79hcMW2h-P2RTnMTqcfEZXzZT8v3z8BVsXqEo</recordid><startdate>200605</startdate><enddate>200605</enddate><creator>Sax, H.</creator><creator>Posfay-Barbe, K.</creator><creator>Harbarth, S.</creator><creator>Francois, P.</creator><creator>Touveneau, S.</creator><creator>Pessoa-Silva, C.L.</creator><creator>Schrenzel, J.</creator><creator>Dharan, S.</creator><creator>Gervaix, A.</creator><creator>Pittet, D.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T2</scope><scope>7U2</scope><scope>C1K</scope><scope>7X8</scope></search><sort><creationdate>200605</creationdate><title>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</title><author>Sax, H. ; Posfay-Barbe, K. ; Harbarth, S. ; Francois, P. ; Touveneau, S. ; Pessoa-Silva, C.L. ; Schrenzel, J. ; Dharan, S. ; Gervaix, A. ; Pittet, D.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c396t-8d1d5bc00085b38882ed202f92569b1b592cfd1c379f5f78162e3db1e9a8a6963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adult</topic><topic>Anti-Bacterial Agents - therapeutic use</topic><topic>Antibacterial agents</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Bacterial diseases</topic><topic>Biological and medical sciences</topic><topic>Community-Acquired Infections - microbiology</topic><topic>Community-Acquired Infections - prevention &amp; control</topic><topic>Community-Acquired Infections - transmission</topic><topic>Community-associated infections/microbiology/transmission</topic><topic>Cross-infection/microbiology/transmission</topic><topic>Disease Outbreaks</topic><topic>Disease transmission, vertical</topic><topic>Human bacterial diseases</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>Infection Control - methods</topic><topic>Infectious diseases</topic><topic>Intensive Care Units, Neonatal</topic><topic>Medical sciences</topic><topic>Methicillin Resistance</topic><topic>Pharmacology. Drug treatments</topic><topic>Staphylococcal Infections - drug therapy</topic><topic>Staphylococcal Infections - epidemiology</topic><topic>Staphylococcal Infections - transmission</topic><topic>Staphylococcal infections, streptococcal infections, pneumococcal infections</topic><topic>Staphylococcal infections/microbiology/transmission</topic><topic>Staphylococcus aureus</topic><topic>Staphylococcus aureus - drug effects</topic><topic>Staphylococcus aureus - isolation &amp; purification</topic><topic>Staphylococcus aureus - pathogenicity</topic><topic>Switzerland - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sax, H.</creatorcontrib><creatorcontrib>Posfay-Barbe, K.</creatorcontrib><creatorcontrib>Harbarth, S.</creatorcontrib><creatorcontrib>Francois, P.</creatorcontrib><creatorcontrib>Touveneau, S.</creatorcontrib><creatorcontrib>Pessoa-Silva, C.L.</creatorcontrib><creatorcontrib>Schrenzel, J.</creatorcontrib><creatorcontrib>Dharan, S.</creatorcontrib><creatorcontrib>Gervaix, A.</creatorcontrib><creatorcontrib>Pittet, D.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Environmental Sciences and Pollution Management</collection><collection>MEDLINE - Academic</collection><jtitle>The Journal of hospital infection</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sax, H.</au><au>Posfay-Barbe, K.</au><au>Harbarth, S.</au><au>Francois, P.</au><au>Touveneau, S.</au><au>Pessoa-Silva, C.L.</au><au>Schrenzel, J.</au><au>Dharan, S.</au><au>Gervaix, A.</au><au>Pittet, D.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology</atitle><jtitle>The Journal of hospital infection</jtitle><addtitle>J Hosp Infect</addtitle><date>2006-05</date><risdate>2006</risdate><volume>63</volume><issue>1</issue><spage>93</spage><epage>100</epage><pages>93-100</pages><issn>0195-6701</issn><eissn>1532-2939</eissn><abstract>To control an outbreak of community-associated MRSA (CA-MRSA) in a neonatology unit, an investigation was conducted that involved screening neonates and parents, molecular analysis of MRSA isolates and long-term follow-up of cases. During a two-month period in the summer of 2000, Panton-Valentine leukocidin (PVL)-producing CA-MRSA (strain ST5-MRSA-IV) was detected in five neonates. The mother of the index caseshowed signs of mastitis and wound infection and consequently tested positive for CA-MRSA. A small cluster of endemic, PVL-negative MRSA strains (ST228-MRSA-I) occurred in parallel. Enhanced hygiene measures, barrier precautions, topical decolonization of carriers, and cohorting of new admissions terminated the outbreak. Four months after the outbreak, the mother of another neonate developed furunculosis with the epidemic CA-MRSA strain. One infant had persistent CA-MRSA carriage resulting in skin infection in a sibling four years after the outbreak. In conclusion, an epidemic CA-MRSA strain was introduced by the mother of the index case. This spread among neonates and was subsequently transmitted to another mother and a sibling. This is the first report of a successfully controlled neonatology outbreak of genetically distinct PVL-producing CA-MRSA in Europe.</abstract><cop>Kent</cop><pub>Elsevier Ltd</pub><pmid>16542756</pmid><doi>10.1016/j.jhin.2005.11.016</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0195-6701
ispartof The Journal of hospital infection, 2006-05, Vol.63 (1), p.93-100
issn 0195-6701
1532-2939
language eng
recordid cdi_proquest_miscellaneous_67889107
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Adult
Anti-Bacterial Agents - therapeutic use
Antibacterial agents
Antibiotics. Antiinfectious agents. Antiparasitic agents
Bacterial diseases
Biological and medical sciences
Community-Acquired Infections - microbiology
Community-Acquired Infections - prevention & control
Community-Acquired Infections - transmission
Community-associated infections/microbiology/transmission
Cross-infection/microbiology/transmission
Disease Outbreaks
Disease transmission, vertical
Human bacterial diseases
Humans
Infant, Newborn
Infection Control - methods
Infectious diseases
Intensive Care Units, Neonatal
Medical sciences
Methicillin Resistance
Pharmacology. Drug treatments
Staphylococcal Infections - drug therapy
Staphylococcal Infections - epidemiology
Staphylococcal Infections - transmission
Staphylococcal infections, streptococcal infections, pneumococcal infections
Staphylococcal infections/microbiology/transmission
Staphylococcus aureus
Staphylococcus aureus - drug effects
Staphylococcus aureus - isolation & purification
Staphylococcus aureus - pathogenicity
Switzerland - epidemiology
title Control of a cluster of community-associated, methicillin-resistant Staphylococcus aureus in neonatology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T13%3A27%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Control%20of%20a%20cluster%20of%20community-associated,%20methicillin-resistant%20Staphylococcus%20aureus%20in%20neonatology&rft.jtitle=The%20Journal%20of%20hospital%20infection&rft.au=Sax,%20H.&rft.date=2006-05&rft.volume=63&rft.issue=1&rft.spage=93&rft.epage=100&rft.pages=93-100&rft.issn=0195-6701&rft.eissn=1532-2939&rft_id=info:doi/10.1016/j.jhin.2005.11.016&rft_dat=%3Cproquest_cross%3E67889107%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17166878&rft_id=info:pmid/16542756&rft_els_id=S0195670106000053&rfr_iscdi=true